Nevertheless, considering the crucial role of NCL in cancer development, numerous studies have investigated NCL as a key receptor for therapeutic agents and imaging probes.[21, 22, 23] In this study, we employed the X‐As strategy on clinical bladder cancer tissues to generate a novel single‐stranded DNA aptamer named TB‐5. The gene discussed is NUCLEOLIN; the disease is urinary bladder carcinoma.